Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Clin Genet. 2022 Apr 12;101(5-6):530–540. doi: 10.1111/cge.14132

Table 1.

Characteristics of subjects included in this report

Subject 1
(F1-II3)
2
(F1-II7)
3
(F2-II3)
4
(F3-II1)
5
(F3-II2)
6
(F4-II5)
7
(F5-III2)
8
(F5-III3)
9
(F5-III11)
10
(F6-II4)
11
(F6-II8)
12
(F7-II3)
Total
Gender Female Male Male Male Male Male Female Female Male Female Male Female 7 males:
5 females
Ethnicity Arab Arab Cree Arab Arab Arab Arab Arab Arab Arab Arab Iranian
Country of origin Egypt Egypt USA Egypt Egypt Egypt Saudi Arabia Saudi Arabia Saudi Arabia Saudi Arabia Saudi Arabia Iran
Consanguinity + + + + + + + + + + + 11/12
WDR45B variant c.674G>A; p.R225Q c.674G>A; p. R225Q c.428–10_435del18 c.619–3A>G c.619–3A>G c.673C>T; p.R225* c.427+4A>G c.427+4A>G c.427+4A>G c.427+4A>G c.427+4A>G c.67+1G>T
Age at last evaluation 14 years 4 years 21 months 6 years 22 months 7 months 8 years 10 years 11 years 15 years 3 years 3 years 7 months-15 years
Outcome Alive Alive Alive Alive Deceased Alive Deceased Alive Deceased Deceased Alive Deceased 5 deceased: 7 alive
Growth at birth
Weight in kg (SD)
Height in Cm (SD)
OFC in Cm (SD)
3 (−2)
NA
NA
2.15(−2.2)
NA
NA
2.45(−2)
NA
NA (Microcephaly)
3(−1)
49(−0.5)
30(−3.2)
NA
NA
NA
2.25(−2.5)
48(−1.1)
31(−2.6)
NA
NA
NA
NA
NA
NA
2.6(−1.5)
NA
33(−1.3)
NA
NA
NA
(Brain atrophy)
NA
NA
NA
NA
NA
NA
Growth at last evaluation
Weight in kg (SD)
Height in Cm (SD)
OFC in Cm (SD)
46 (−0.7)
147.5(−2.2)
49.5(−3.7)
16 (−1)
99(−0.8)
48(−2.3)
12.1(0.4)
77(−2.8)
40.5(−5.5)
12.7(−3.5)
88 (−5.4)
40 (−8.7)
7(−4.7)
73(−4.1)
36(−8.9)
6.8 (−1.8)
67(−0.6)
37.5(−5)
15.1(−5.6)
115(−3.6)
46(−4)
16.6(−4.7)
115(−3.6)
44.5(−4.2)
13.5 (−8.3)
102(−6)
44(−7)
NA
103(−7.7)
42 (−9.1)
7(−5.4)
62(−9.1)
43.5(−3.3)
6(−11)
81(−3.3)
39(−6)
Microcephaly + + + + + + + + + + + + 12/12
Developmental delay + + + + + + + + + + + + 12/12
Epilepsy
(Semiology)
+(GTC) + + (Myoclonic) + (Myoclonic, tonic) + (Myoclonic, GTC) + (Focal, GTC, myoclonic) + (Focal, GTC, myoclonic) + (Focal, GTC) +(GTC) +(GTC) + 11/12
Epilepsy onset 6 months 3 months 2 months 1 month Few days after birth 12 days 1.5 months 2 months 2 months Neonatal period NA Few days-6 months
Drug-resistant epilepsy + + + + + + + + + + + 11/12
EEG Theta background with no sharp waves or spikes Normal Sharp waves in the left central and right frontal regions Generalized epileptogenic activity Generalized epileptogenic activity Generalized epileptogenic activity Diffuse slowing and attenuation Frequent sharp wave discharges over the right posterior quadrant Diffuse nonspecific slowing with poorly organized background with no epileptiform discharges NA NA NA
Spastic Quadriplegia − (lower limbs only) + + + + + + + + + NA 9/11
Facial Features
Bitemporal narrowing + NA + NA NA NA + + NA 4/7
Thick and arched eyebrows + NA + NA + (Arched only) NA NA + (with synophrys) + NA 5/7
Large ears NA + NA + NA NA + + + NA 5/7
Long philtrum NA + NA + NA NA + + (smooth) NA 4/7
Others Facial asymmetry, upslanted and narrow PF, hypertelorism, fullness of upper eyelids, full cheeks Broad forehead, epicanthal folds NA Long face, downslanted PF, thin upper lip, broad chin
NA
(Reported similar to Subject four)
Narrow PF, hypertelorism, thick lips, retromicrognathia
NA NA Elongated face, epicanthal folds, hypertelorism, depressed nasal bridge, maxillary hypoplasia, elongated jaw Triangular face, hypertelorism, gum hyperplasia, Elongated face, depressed nasal bridge, maxillary hypoplasia, elongated jaw NA

Cm: Centimeters; EEG: electroencephalogram; GTC: generalized tonic clonic; Kg: Kilograms; NA: not available; PF: palpebral fissure; SD: standard deviation.

OFC obtained at 5 years of age